Evidence map›Paper›PMID 39501108›Full record

ReviewNature protocols2025

Life-long functional regeneration of in vivo airway epithelium by the engraftment of airway basal stem cells.

Liang Ma, Bibek R Thapa, Jake A Le Suer, Andrew Tilston-Lünel, Michael J Herriges, Feiya Wang, Pushpinder S Bawa, Xaralabos Varelas, Finn J Hawkins, Darrell N Kotton

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Separation of Human P63Analytical chemistry · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Engineered hydrogel biomaterials facilitate lung progenitor cell differentiation from induced pluripotent stem cells.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  8. Review
  9. THERAPIES FOR NEONATAL DISEASES OF THE SURFACTANT SYSTEM.Transactions of the American Clinical and Climatological Association · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Liang MaCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Bibek R ThapaCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Jake A Le SuerCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Andrew Tilston-LünelHerman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
Michael J HerrigesCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Feiya WangCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Pushpinder S BawaCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Xaralabos VarelasCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.ORCID 0000-0002-2882-4541
Finn J HawkinsCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.ORCID 0000-0002-2246-6448
Darrell N KottonCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA. dkotton@bu.edu.ORCID 0000-0002-9604-8476

Funding

Patient-specific iPSCs to model and treat the inception of pulmonary fibrosisP01HL170952 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ANDREW A WILSON · 2024 to 2026
$11.4M
Editing Alveolar Progenitor Cells for Correction of Monogenic DiseaseU01HL134745 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTON, DARRELL N., MORRISEY, EDWARD E · 2016 to 2022
$8.3M
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damageU01HL134766 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAPMAN, HAROLD A, KOTTON, DARRELL N. · 2016 to 2022
$8.1M
Derivation of Transplantable Lung Epithelial Progenitors from iPS CellsR01HL095993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2009 to 2026
$7.5M
Defining epithelial polarity cues that direct cell fateR01HL124392 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VARELAS, XARALABOS · 2014 to 2024
$4.5M
NATIONAL BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS:THE PURPOSE OF THIS RESOURCE IS TO BUILD AND SUPPORT A CRITICAL75N92020C00005 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI N/A, N/A · 2021 to 2024
$2.6M
iPSC-Derived Airway Basal Cells to Model Human Airway Development and DiseaseR01HL139799 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAWKINS, FINN · 2018 to 2022
$2.1M
Generation of functional lung stem cells from human iPSCsU01HL148692 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Finn Hawkins, Darrell N. Kotton · 2019 to 2026
$2.0M
Defining non-nuclear roles for Yap in the development of multi-ciliated cellsR21HD094012 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VARELAS, XARALABOS · 2018 to 2019
$454k
Cystic Fibrosis Foundation (CF Foundation) HAWKIN20XX2NHLBI NIH HHS 75N92020C00005NHLBI NIH HHS P01 HL170952NHLBI NIH HHS R01 HL095993NHLBI NIH HHS R01 HL124392NHLBI NIH HHS R01 HL139799NHLBI NIH HHS U01 HL134745NHLBI NIH HHS U01 HL134766NHLBI NIH HHS U01 HL148692NICHD NIH HHS R21 HD094012U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R21HD094012U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) NO1: 75N92020C00005U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) P01HL170952U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) PCTC Jumpstart AwardU.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL095993U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL124392U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL139799U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) U01HL134766U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) U01HL148692
6 · The paper itself

Abstract

Durable and functional regeneration of the airway epithelium in vivo with transplanted stem cells has the potential to reconstitute healthy tissue in diseased airways, such as in cystic fibrosis or primary ciliary dyskinesia. Here, we present detailed protocols for the preparation and culture expansion of murine primary and induced pluripotent stem cell-derived airway basal stem cells (iBCs) and methods for their intra-airway transplantation into polidocanol-conditioned murine recipients to achieve durable in vivo airway regeneration. Reconstitution of the airway tissue resident epithelial stem cell compartment of immunocompetent mice with syngeneic donor cells leverages the extensive self-renewal and multipotent differentiation properties of basal stem cells (BCs) to durably generate a broad diversity of mature airway epithelial lineages in vivo. Engrafted donor-derived cells re-establish planar cell polarity as well as functional ciliary transport. By using this same approach, human primary BCs or iBCs transplanted into NOD-SCID gamma recipient mice similarly display engraftment and multilineage airway epithelial differentiation in vivo. The time to generate mouse or human iBCs takes ~60 d, which can be reduced to ~20 d if previously differentiated cells are thawed from cryopreserved iBC archives. The tracheal conditioning regimen and cell transplantation procedure is completed in 1 d. A competent graduate student or postdoctoral trainee should be able to perform the procedures listed in this protocol.

Indexed as

RegenerationRespiratory MucosaStem Cell TransplantationAnimalsCell DifferentiationEpithelial CellsHumansInduced Pluripotent Stem CellsMiceMice, Inbred NODMice, SCID

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.